Inter-society consensus for the management of respiratory infections: Acute bronchitis and chronic obstructive pulmonary disease;Consenso intersociedades para el manejo de infecciones respiratorias: Bronquitis aguda y enfermedad pulmonar obstructiva crónica

Medicina (Argentina)

Volumn 73, Issue 2, 2013, Pages 163-173

  Lopardo, Gustavo ^a   Pensotti, Claudia ^a   Scapellato, Pablo ^a   Caberlotto, Oscar ^b   Calmaggi, Aníbal ^a   Clara, Liliana ^a   Klein, Manuel ^a   Hara, Gabriel Levy ^a   López Furst, María J ^a   Mykietiuk, Analía ^a   Pryluka, Daniel ^a   Rial, Maria J ^c   Vujacich, Claudia ^a   Yahni, Diego ^a  

^a Sociedad Argentina de Infectología ^*  (Argentina)

^b Asociación Argentina de Medicina Respiratoria ^*  (Argentina)

^c Micología y Parasitología Clínica SADEBAC   (Argentina)

Author keywords

Acute bronchitis; COPD reactivation; Management of respiratory infections

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; MACROLIDE; QUINOLONE DERIVATIVE;

ADULT DISEASE; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CHILDHOOD DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONSENSUS; DYSPNEA; HEART DISEASE; HOST; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; LUNG DISEASE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; VIRUS INFECTION; VIRUS REACTIVATION;

ACUTE BRONCHITIS; COPD REACTIVATION; MANAGEMENT OF RESPIRATORY INFECTIONS;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ARGENTINA; BRONCHITIS; DYSPNEA; EVIDENCE-BASED MEDICINE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SOCIETIES, MEDICAL; SPUTUM;

EID: 84877901912     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Gonzales R, Steiner JF, Lum A, Barrett PH, Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512-9.
2. Clinical Practice Guidelines Manager. Guideline for the management of acute bronchitis. TOP Program. (Updated January 2008). En: http://www.topalbertadoctors.org/; consultado el 26/3/2011.
3. Hueston WJ, Mainous AG 3rd, Dacus EN, Hopper JE. Does acute bronchitis really exist? A reconceptualization of acute viral respiratory infections. J Fam Pract 2000; 49: 401-6.
4. Wenzel RP, Fowler AA. Clinical practice. Acute bronchitis. N Engl J Med 2006; 355: 2125-30.
5. Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000; 133: 981-91.
6. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001; 134: 521-9.
7. Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK. Treatment of acute bronchitis in adults. A national survey of family physicians. J Fam Pract 1998; 46: 469-75
8. Hueston WJ, Hopper JE, Dacus EN, Mainous AG. Why are antibiotics prescribed for patients with acute bronchitis? A postintervention analysis. J Am Board Fam Pract 2000; 13: 398-402.
9. Ward JI, Cherry JD, Chang SJ, et al. APERT Study Group. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63.
10. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278: 1440-5.
11. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Emerg Med 2001; 37: 720-7.
12. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004: CD000245. DOI: 10.1002/14651858.
13. Orr P, Scherer K, Macdonald A, Moffat ME. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J.Fam Pract 1993; 36: 507-12.
14. Franks P, Gleiner J. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J. Fam Pract 1984; 19: 185-90.
15. Verheij T, Hermans J, Mulder J. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract 1994; 44: 400-4.
16. King D, Williams W, Bishop L, Shechter A. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 1996; 42: 601-5.
17. Gadomski A. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12:115-20.
18. Bent S, Saint S, Vittinghoff E, Grady D. Antibiotics in acute bronchitis: a meta-analysis. Am J Med 1999; 107: 62-7.
19. Bent S, Saint S, Vittinghoff E, Grady D. In-patients with acute bronchitis, do antibiotics reduce sputum production, cough, or number of days off work? West J Med 2000; 173: 115.
20. Linder JA, Sim I. Antibiotic treatment of acute bronchitis in smokers: a systematic review. J Gen Intern Med 2002; 17: 230-4.
21. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004: CD000245.
22. Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002; 359: 1648-54.
23. Nduba VN, Mwachari CW, Magaret AS, et al. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial. Thorax 2008; 63: 999-1005.
24. Hamm R, Hicks R, Bemben D. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 1996; 43: 56-62
25. Little P, Watson L, Morgan M Williamson I. Antibiotic prescribing and admissions with major suppurative complications of respiratory tract infections: a data linkage study. Br J Gen Pract 2002; 52: 187-93.
26. Dowell J, Pitkethly M, Bain J Martin S. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract 2001; 51: 200-5.
27. National Institute for Health and Clinical Excellence. NICE clinical guideline 69 Respiratory tract infections - antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. (Updated July 2008). En: http://www.nice.org.uk/nicemedia/pdf/CG69FullGuidelineAppendices.pdf; consultado el 26/3/2011.
28. Smucny J, Becker L, Glazier R. Beta2 agonists for acute bronchitis. Cochrane Database Syst Rev 2004: CD001726.
29. Peces-Barba G, Barberà JA, Agustí A, et al. Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Arch Bronconeumol 2008; 44: 271-81.
30. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
31. Sivori ML, Sáenz CB, Riva Posse C. Mortalidad por asma y enfermedad pulmonar obstructiva crónica en Argentina en el período 1980-1998. Medicina (B Aires) 2001; 61: 513-21.
32. Miravitles M, Jardim JR, Zitto T, et al. Pharmacoeconomic study of antibiotic therapy for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America. Arch Bronconeumol 2003; 39: 549-53.
33. GOLD executive committee. Global initiative for Chronic Obstructive Pulmonary Disease. En: www.goldcopd.com; consultado el 11/2/2011.
34. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
35. Miravitlles M. Do we need new antibiotics for treating exacerbations of COPD? Ther Adv Respir Dis 2007; 1: 61-76.
36. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbation of COPD. Chest 2000; 117: 1638-45.
37. Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre antibioticoterapia y farmacoeconomía en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121: 1449-55.
38. Sethi S, Evans N, Grant BJB, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-71.
39. Brunton S, Carmichael BP, Colgan C, et al. Acute exacerbation of chronic bronchitis: a primary care consensus guideline. Am J Manag Care 2004; 10: 689-96.
40. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004; 24: 171-81.
41. Filler J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113: 1542-48.
42. Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group in Bacterial Infections in COPD. Chest 1999; 116: 40-6.
43. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 1995; 273: 957-60.
44. Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res 2007; 8: 30.
45. Stoller JK. Acute exacerbations of chronic obstructive pulmonary disease. N Eng J Med 2002; 346: 988-94
46. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118: 1557-65.
47. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17: 1112-9.
48. Daniels JM, Schoorl M, Snijders D, et al. Procalcitonin vs. C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 2010; 138: 1108-15.
49. Schuetz P, Christ-Crain M, Thomann R, et al; ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009; 302: 1059-66.
50. Grupo de Trabajo de SIREVA II Informe Regional de SIREVA II: Organización Panamericana de la Salud. Informe Regional de SIREVA II, 2010: datos por país y por grupo de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores. Washington D.C.: OPS, 2011. En: http://new.paho.org/hq/index.php?option=com_content&task=blogcategory&id=3609&Itemid=3953; consultado el 27/6/2012.
51. Siempos II, Dimopoulus G, Korbila IP, Manta K, Falagas ME. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis. Eur Respir J 2007; 29: 1127-37.
52. Mclvor RA. Antibiotics in acute exacerbations of chronic obstructive pulmonary disease. Can Fam Physician 2009; 55: 15-6.
53. Donner CF. Acute exacerbation of chronic bronchitis: need for an evidence-based approach. Pul Pharmacol Ther 2006; 19: 4-10.
54. Singh A. Quinolones to treat acute bacterial exacerbation of chronic bronchitis in TB endemic areas: a word of caution. Eur Respir J 2007; 30: 1233-5.
55. Balter MS, La Forge J, Low DE, Mandell L, Grossman RF; Chronic Bronchitis Working Group; Canadian Thoracic Society; Canadian Infectious Disease Society. Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can Respir J 2003; 10: 248-58.
56. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157:1498-505.
57. Siddiqi A, Sethi S. Optimizing antibiotic selection in healthy COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2008; 3: 31-44.
58. Falagas ME, Avgeri AG, Matthaiou DK, Dimopoulus G, Tiempos II Short-versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother 2008; 62: 442-50.
59. El Moussaoui R, Roede BM, Speelman P, Bresser P, Prins JM, Bossuyt PMM. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax 2008; 63: 415-22.
60. Maraffi T, Piffer F, Cosentini R. Prophylactic antibiotic therapy in chronic obstructive pulmonary disease. Ther Adv Respir Dis 2010; 4: 135-42.
61. Woodhead M, Blasi F, Ewing S, Huchon G, Ieven M, Ortqvist A, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-80.
62. Stakyova T, Blacke P, Chacko E, Ram FSF, Poole P. Tratamiento profiláctico con antibióticos para la bronquitis crónica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. En: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.).
63. Seemungal TA, Wilkinson TM, Hurst JR, Perera WR, Sapsoford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008; 178: 1139-47.
64. Miravitlles M, Marin A, Monsó E, et al. Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD. Eur Respir J 2009; 34: 1066-71.
65. Sethi S, Jones PW, Theron M, et al. PULSE Study Group. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial. Respir Res 2010; 11: 10.
66. Sethi S, Alder J. Intermittent moxifloxacin effective in reducing exacerbations, bacterial burden in patients with COPD-the PULSE study. 19th European Congress of Clinical Microbiology and Infectious Diseases, 2009 Mayo 16-19 Helsinki, Finland (Poster).